查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659425

全球次世代定序儀(NGS) 樣品製備市場

Next Generation Sequencing (NGS) Sample Preparation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 88 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球次世代定序儀(NGS) 樣品製備市場規模將達到 105 億美元

2024 年全球次世代定序儀(NGS) 樣品製備市場規模估計為 39 億美元，預計到 2030 年將達到 105 億美元，2024 年至 2030 年的複合年成長率為 18.2%。試劑和消耗品是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 19.7%，達到 69 億美元。在分析期間內，工作站部分的複合年成長率預計為 15.5%。

美國市場預估達 11 億美元，中國市場複合年成長率達 17.0%

預計 2024 年美國次世代定序儀(NGS) 樣品製備市場規模將達 11 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 16 億美元，2024-2030 年分析期間的複合年成長率為 17.0%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 16.0% 和 15.2%。在歐洲，預計德國的複合年成長率約為 13.0%。

全球次世代定序儀(NGS) 樣品製備市場 - 主要趨勢與促進因素摘要

次世代定序儀（NGS）樣本製備將如何推動基因組學的發展？

次世代定序儀(NGS) 樣本製備是基因組序列測定過程中的關鍵步驟，可實現對 DNA 和 RNA 的準確分析，以用於研究、臨床診斷和個人化醫療。該過程包括 DNA/RNA 萃取、文庫製備和目標富集，所有這些對於獲得高品質的定序結果至關重要。隨著自動化、連接複用和單細胞分析等創新的出現，NGS 樣品製備取得了重大進展，從而實現了更快、更準確的基因組分析。隨著基因組學成為了解疾病、藥物開發和群體遺傳學不可或缺的一部分，高效的樣品製備對於充分發揮 NGS 技術的潛力至關重要。

NGS 樣品製備市場的關鍵部分有哪些？

主要產品包括試劑、套件、儀器和耗材，其中試劑和套件佔據市場主導地位，常用於文庫製備和目標富集。工作流程包括 DNA 萃取、文庫製備和目標富集，其中文庫製備是最大的部分。主要最終用戶包括學術研究機構、醫院、製藥公司和臨床實驗室，他們都使用 NGS 樣本製備來進行基因組研究、開發個人化治療方法和診斷遺傳疾病。

NGS 樣品製備是如何跨學科應用的？

學術研究機構是NGS樣本製備的最大用戶，將其用於基因組研究、基因表現研究和生物標記發現。醫院和臨床實驗室使用NGS樣本製備來診斷遺傳疾病、檢測感染疾病並指導個人化治療方案。製藥公司利用基因組數據來確定基因標靶、開發新藥、進行臨床試驗，基因組資料在藥物療效分析中發揮重要作用。人們對群體遺傳學和精準醫療的興趣日益濃厚，進一步推動了政府資助的基因組計劃和需要大規模定序進行基因分析的生物庫採用NGS樣本製備。

哪些因素推動了NGS樣品製備市場的成長？

下一代定序樣本製備市場的成長受到多種因素的推動，包括疾病研究、個人化醫療和藥物開發對基因組學的需求不斷增加。自動化和連接複用技術的進步提高了樣品製備的效率和準確性，並提高了整體 NGS 工作流程的速度。精準醫療的興起嚴重依賴基因洞察，這進一步增加了對先進樣本製備技術的需求。政府對基因組研究的舉措和資助，加上臨床基因組學的擴展，促進了市場的成長。 NGS 在癌症診斷、罕見疾病檢測和感染疾病監測中的應用日益增多，也推動了高效樣品製備解決方案的需求。

部分

產品類型（試劑和耗材、工作站）、工作流程（半自動化文庫製備、 NGS庫製備套件、自動化文庫製備、克隆擴增）、應用（腫瘤學、消費者基因總體基因體學、流行病學和研發、農業基因組學和法醫學、 HLA型檢測和免疫製藥系統監測、其他學術應用程式和研究

受訪公司範例（總合32家公司）

  • Agilent Technologies
  • Beckman Coulter（A Subsidiary of Danaher）
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen NV
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP22379

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach US$10.5 Billion by 2030

The global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.9 Billion in the year 2024, is expected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.2% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Workstations segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 17.0% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Next Generation Sequencing (NGS) Sample Preparation Market - Key Trends and Drivers Summarized

How Is Next Generation Sequencing (NGS) Sample Preparation Evolving Genomics?

Next Generation Sequencing (NGS) Sample Preparation is a crucial step in the genomic sequencing process, enabling the accurate analysis of DNA and RNA for research, clinical diagnostics, and personalized medicine. This process involves DNA/RNA extraction, library preparation, and target enrichment, all of which are critical for obtaining high-quality sequencing results. NGS sample preparation has advanced significantly with innovations such as automation, multiplexing, and single-cell analysis, allowing for faster and more precise genomic analysis. As genomics becomes integral to understanding diseases, drug development, and population genetics, efficient sample preparation is essential for unlocking the full potential of NGS technologies.

What Are the Key Segments in the NGS Sample Preparation Market?

Key products include reagents, kits, instruments, and consumables, with reagents and kits dominating the market due to their frequent use in library preparation and target enrichment. In terms of workflow, the market covers DNA extraction, library preparation, and target enrichment, with library preparation being the largest segment. Major end-users include academic research institutions, hospitals, pharmaceutical companies, and clinical laboratories, all of which use NGS sample preparation to conduct genomic studies, develop personalized therapies, and diagnose genetic disorders.

How Is NGS Sample Preparation Being Adopted Across Sectors?

Academic research institutions are the largest users of NGS sample preparation, utilizing it for genomic research, gene expression studies, and biomarker discovery. Hospitals and clinical laboratories leverage NGS sample preparation for diagnosing genetic disorders, detecting infectious diseases, and guiding personalized treatment plans. Pharmaceutical companies use it to identify genetic targets, develop new drugs, and conduct clinical trials, where genomic data plays a critical role in drug efficacy analysis. The growing interest in population genetics and precision medicine is further driving the adoption of NGS sample preparation in government-funded genomic projects and biobanks, which require large-scale sequencing for genetic analysis.

What Factors Are Driving the Growth in the NGS Sample Preparation Market?

The growth in the Next Generation Sequencing Sample Preparation market is driven by several factors, including the increasing demand for genomics in disease research, personalized medicine, and drug development. Technological advancements in automation and multiplexing have improved the efficiency and accuracy of sample preparation, enhancing the overall speed of NGS workflows. The rise of precision medicine, which relies heavily on genetic insights, has further fueled the need for advanced sample preparation techniques. Government initiatives and funding for genomic research, coupled with the expansion of clinical genomics, are contributing to market growth. The increasing use of NGS in cancer diagnostics, rare disease detection, and infectious disease monitoring is also driving the demand for efficient sample preparation solutions.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencing (NGS) Sample Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Workstations); Workflow (Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation, Clonal Amplification); Application (Oncology, Consumer Genomics, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications); End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Next Generation Sequencing (NGS) Sample Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Sequencing Spurs Growth in NGS Sample Preparation Market
    • Technological Advancements in Automation and Library Preparation Kits Strengthen Business Case for Adoption
    • Growing Focus on Precision Medicine and Genomic Research Expands Addressable Market for NGS Sample Preparation
    • Expansion of NGS Sample Preparation in Academic Research and Clinical Laboratories Fuels Market Growth
    • Increasing Adoption of NGS Sample Preparation in Cancer Genomics, Infectious Disease, and Genetic Disorders Expands Market Opportunities
    • Technological Innovations in Single-Cell Sequencing and RNA Sequencing Propel Market Expansion
    • Rising Focus on Reducing Turnaround Time and Cost per Sample Drives Demand for NGS Sample Preparation
    • Growing Use of NGS Sample Preparation in Pharmacogenomics and Drug Development Expands Market Potential
    • Technological Advancements in Multiplex PCR, Target Enrichment, and Library Construction Propel Market Growth
    • Increasing Focus on Integrating NGS Sample Preparation with Bioinformatics Pipelines Drives Adoption
    • Rising Demand for NGS Sample Preparation in Plant Genomics, Microbiome, and Epigenetics Research Strengthens Global Market
    • Expansion of NGS Sample Preparation in Liquid Biopsy and Minimal Residual Disease Testing Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Semi-Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Semi-Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for NGS Library Preparation Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for NGS Library Preparation Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clonal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Clonal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Metagenomics, Epidemiology & Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Metagenomics, Epidemiology & Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agrigenomics & Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Agrigenomics & Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for HLA Typing / Immune System Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for HLA Typing / Immune System Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 28: World 6-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 31: World Next Generation Sequencing (NGS) Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • JAPAN
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CHINA
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • EUROPE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • FRANCE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • GERMANY
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030

IV. COMPETITION